Related Experiment Video

Updated: Jun 14, 2025

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

1.6K

Recent advances in serum response factor posttranslational modifications and their therapeutic potential in

Alexander Visconti1, Hongyu Qiu2

  • 1Cardiovascular Translational Research Center, Department of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA.

Vascular Pharmacology
|August 29, 2024
PubMed

Insights

Serum Response Factor (SRF) post-translational modifications (PTMs) are crucial for its function and linked to diseases. Targeting SRF PTMs offers a promising therapeutic strategy for SRF-associated conditions.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Serum Response Factor (SRF) is a vital transcription factor regulating cellular functions.
  • Aberrant SRF activity and mutations are implicated in various diseases.
  • Post-translational modifications (PTMs) critically influence SRF function and disease pathogenesis.

Purpose of the Study:

  • To review recent advances in understanding SRF PTMs and their regulatory mechanisms.
  • To explore the role of SRF-PTMs in cardiovascular and neurological diseases.
  • To highlight the therapeutic potential of targeting SRF PTMs.

Main Methods:

  • Literature review of recent studies on SRF PTMs.
  • Analysis of regulatory mechanisms governing SRF PTMs.
  • Examination of SRF-PTM implications in disease contexts.

Main Results:

  • PTMs are essential for regulating SRF activity in diverse cell types.
  • Specific SRF PTMs are linked to the pathogenesis of cardiovascular and neurological disorders.
  • Targeting SRF PTMs presents a novel therapeutic avenue.

Conclusions:

  • SRF PTMs play significant roles in both physiological processes and disease development.
  • Understanding SRF PTMs enhances knowledge of disease mechanisms.
  • SRF PTMs offer promising targets for developing new therapeutic strategies.
Keywords:
Cardiovascular diseasesNeurological diseasesPosttranslational modificationsSerum response factor

More Related Videos

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model06:03

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Published on: June 11, 2020

9.0K
Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice08:09

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

8.1K

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404